Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment-Reference-Cited by-同舟云学术

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment

Published:2011-01 Issue:1 Volume:25 Page:63-72
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Wattmo Carina,Wallin Åsa K.,Londos Elisabet,Minthon Lennart

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference1 articles.

1. Efficacy and safety of galantamine in patients with mild to moderate Alzheimers disease: multicentre randomised controlled trial. Galantamine International-1 Study Group BMJ (Clinical research ed.;Wilcock;),2000

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment;Journal of Alzheimer's Disease;2024-04-02

2. Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases;Ageing Research Reviews;2023-02

3. Effect of APOE4 Allele and Gender on the Rate of Atrophy in the Hippocampus, Entorhinal Cortex, and Fusiform Gyrus in Alzheimer’s Disease;Current Alzheimer Research;2022-12

4. Nomogram for predicting the 12-year risk of ADL disability among older adults;Aging Clinical and Experimental Research;2022-03-17

5. Reimagining cholinergic therapy for Alzheimer’s disease;Brain;2022-03-15